중증 폐동맥고혈압이 동반된 만성폐쇄성폐질환 1예
Chronic Obstructive Pulmonary Disease with Severe Pulmonary Hypertension － A Case Report －
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Pulmonary hypertension is an increase in blood pressure in the pulmonary artery, pulmonary vein or pulmonary capillaries. Depending on the cause, pulmonary hypertension can be a severe disease with markedly decreased exercise tolerance and right-sided heart failure. Pulmonary hypertension can present as one of five different types: arterial, venous, hypoxic, thromboembolic, or miscellaneous. Chronic obstructive pulmonary disease with severe pulmonary hypertension is a rare disease. A 52-year-old man presented with a complaint of aggravating dyspnea. The mean pulmonary arterial pressure was 61.5 mmHg by Doppler echocardiogram. The patient was prescribed diuretics, digoxin, bronchodilator, sildenafil, bosentan and an oxygen supply. However, he ultimately died of cor pulmonale. Thus, diagnosis and early combination therapy are important.
Abstract
Pulmonary hypertension is an increase in blood pressure in the pulmonary artery, pulmonary vein or pulmonary capillaries. Depending on the cause, pulmonary hypertension can be a severe disease with markedly decreased exercise tolerance and right-sided heart failure. Pulmonary hypertension can present as one of five different types: arterial, venous, hypoxic, thromboembolic, or miscellaneous. Chronic obstructive pulmonary disease with severe pulmonary hypertension is a rare disease. A 52-year-old man presented with a complaint of aggravating dyspnea. The mean pulmonary arterial pressure was 61.5 mmHg by Doppler echocardiogram. The patient was prescribed diuretics, digoxin, bronchodilator, sildenafil, bosentan and an oxygen supply. However, he ultimately died of cor pulmonale. Thus, diagnosis and early combination therapy are important.
참고문헌 (10)
- Chaouat A, "Severe pulmonary hypertension and chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 172(2), pp.189~194 (2005)
- Rich S, "Primary pulmonary hypertension. A national prospective study", Ann Intern Med, 107(2), pp.216~223 (1987)
- "Proceedings of the 3rd world symposium on pulmonary arterial hypertension. Venice, Italy, June 23-25, 2003", Proceedings of the 3rd world symposium on pulmonary arterial hypertension, 43(12 Suppl S), pp.1S~90 (2004)
- Williams BT, "Prevalence of hypoxaemic chronic obstructive lung disease with reference to long-term oxygen therapy", Lancet, 2(8451), pp.369~372 (1985)
- Weitzenblum E, "Chronic cor pulmonale", Heart, 89(2), pp.225~230 (2003)
- Sitbon O, "Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension", Circulation, 111(23), pp.3105~3111 (2005)
- Olschewski H, "Aerosolized iloprost randomized study group. Inhaled iloprost for severe pulmonary hypertension", N Engl J Med, 347(5), pp.322~329 (2002)
- Rubin LJ, "Bosentan therapy for pulmonary arterial hypertension", N Engl J Med, 346(12), pp.896~903 (2002)
- Galiè N, "Sildenafil citrate therapy for pulmonary arterial hypertension", N Engl J Med, 353(20), pp.2148~2157 (2005)
- Nauser TD, "Diagnosis and treatment of pulmonary hypertension", Am Fam Physician, 63(9), pp.1789~1798 (2001)